Therefore, efforts should focus on identifying a specific DUB candidate or small molecule ligand to attract DUBs that regulate PAH and FAH proteins and designing a PROTAC suitable for freezing the degradation process. This evidence concerns the gene FAH and pulmonary arterial hypertension.